CIK 0001384101 · Large accelerated filer
VERACYTE, INC.
Sign in to watch- Ticker
- VCYT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205455398
- Phone
- (650) 243-6300
- Business address
- 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CALDEROME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,858,989
- in 9 filings, $2.9M under 10b5-1 plans
Net −$2,858,989. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Stapley Marc Chief Executive Officer | Shares withheld for taxes | −19,455 | $36.01 | $701K | 403,077 |
| 2026-02-26 | Leite John Chief Commercial Officer-CLIA | Grant or award | +47,149 | 129,262 | ||
| 2026-02-26 | Leite John Chief Commercial Officer-CLIA | Shares withheld for taxes | −8,905 | $38.75 | $345K | 120,357 |
| 2026-02-26 | McGuire Annie SVP, General Counsel | Grant or award | +50,999 | 119,133 | ||
| 2026-02-26 | McGuire Annie SVP, General Counsel | Shares withheld for taxes | −10,867 | $38.75 | $421K | 108,266 |
| 2026-02-26 | Chambers Rebecca Chief Financial Officer | Grant or award | +59,324 | 168,820 | ||
| 2026-02-26 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes | −12,049 | $38.75 | $467K | 156,771 |
| 2026-02-26 | Febbo Phillip G. Chief Scientific & Med Officer | Grant or award | +71,806 | 161,292 | ||
| 2026-02-26 | Febbo Phillip G. Chief Scientific & Med Officer | Shares withheld for taxes | −24,486 | $38.75 | $949K | 136,806 |
| 2026-02-26 | Stapley Marc Chief Executive Officer | Grant or award | +139,074 | 458,373 | ||
| 2026-02-26 | Stapley Marc Chief Executive Officer | Shares withheld for taxes | −35,841 | $38.75 | $1.4M | 422,532 |
| 2025-12-16 | McGuire Annie SVP, General Counsel | Sale 10b5-1 | −10,639 | $43.13 | $459K | 67,860 |
| 2025-12-16 | McGuire Annie SVP, General Counsel | Sale 10b5-1 | −100 | $43.68 | $4K | 67,760 |
| 2025-12-05 | EASTHAM KARIN Director | Option exercise 10b5-1 | +10,000 | $7.94 | $79K | 23,554 |
| 2025-12-05 | EASTHAM KARIN Director | Option exercise 10b5-1 | +10,000 | $7.60 | $76K | 33,554 |
| 2025-12-05 | EASTHAM KARIN Director | Sale 10b5-1 | −6,392 | $44.52 | $285K | 27,162 |
| 2025-12-05 | EASTHAM KARIN Director | Sale 10b5-1 | −12,808 | $45.84 | $587K | 14,354 |
| 2025-12-05 | EASTHAM KARIN Director | Sale 10b5-1 | −800 | $46.59 | $37K | 13,554 |
| 2025-12-05 | EASTHAM KARIN Director | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2025-12-05 | EASTHAM KARIN Director | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 |
Page 5 of 9 · 168 trades